RecruitingDiabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Eligible age
18–65 yrs
Accepts
All genders
Locations
9 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
Sponsor: Vertex Pharmaceuticals Incorporated
Where it's recruiting
California
Duarte · San Francisco
Florida
Miami
Illinois
Chicago
Maryland
Baltimore
Massachusetts
Boston
Pennsylvania
Philadelphia · Pittsburgh
Texas
Dallas
Virginia
Richmond
Wisconsin
Madison
Source: ClinicalTrials.gov · NCT04786262 · last updated 2026-03-17